Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Odyssey Therapeutics reported its second quarter 2026 results, highlighting positive Phase 2a trial data for its OD-001 program to be presented at a major gastroenterology conference in October. The company plans to initiate Phase 2b monotherapy and Phase 2a combination trials for OD-001 in the second half of 2026, alongside preparing a CTA filing …
Arvinas, Inc. announced the FDA approval of VEPPANU, the first-ever PROTAC degrader approved for breast cancer treatment, and completed a global licensing deal with Rigel Pharmaceuticals. The company reported strong financial results for Q2 2026, driven by increased revenues from partnerships and milestones. Clinical progress includes ongoing Phase…
First Watch Restaurant Group, Inc. released its Q2 2026 financial results, highlighting a 15.2% increase in total revenues to $354.7 million, same-restaurant sales growth of 3.4%, and net income rising to $2.3 million. The company opened 18 new restaurants and updated its fiscal 2026 outlook projecting revenue growth between 12.5% to 14%, and adjus…
X-Energy's subsidiary TRISO-X has acquired an additional 70 acres adjacent to its Oak Ridge, Tennessee nuclear fuel campus, expanding its total footprint to approximately 180 acres. This expansion supports construction and long-term growth plans for advanced nuclear fuel fabrication facilities and research capabilities, reinforcing the region’s lea…
Shoals Technologies Group, Inc., a leader in electrical infrastructure solutions for the energy transition, reported strong Q2 2026 financial results, with revenue increasing 47.4% to $163.4 million and a record backlog and awarded orders of $801.4 million. Although gross margin declined primarily due to operational inefficiencies from transitionin…
CAMP4 Therapeutics completed the second closing of a $100 million private placement, raising approximately $50.1 million to fund clinical development of CMP-002, a lead antisense oligonucleotide targeting SYNGAP1-related disorder, and other early-stage programs. The company aims to initiate a Phase 1/2 trial in Australia, advancing its pipeline of …
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company focusing on novel FASN inhibitors targeting metabolic and fibrotic pathways, announced management's participation in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 11, 2026.
iBio, a clinical-stage biotechnology company focused on long-acting antibody therapeutics for obesity and cardiometabolic diseases, has appointed Dr. Molly Carr as Chief Medical Officer. Dr. Carr brings over 30 years of experience in endocrinology and metabolic disease, having held senior roles at major biopharmaceutical companies. Her leadership i…
Aclarion, Inc. announced that its Nociscan platform for identifying the source of chronic low back pain is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, the first site in Indiana to offer this technology. This expansion marks growth in Aclarion's provider network and aligns the company with a nationally recognized neuros…
RYTHM, Inc. reported robust financial results for Q2 2026, with revenue from continuing operations reaching $23 million, up 73% quarter-over-quarter. The company achieved net income of $1.2 million and an adjusted EBITDA of $6.4 million, marking a significant turnaround from breakeven in the prior quarter. Growth in THC beverage shipments and new s…
Descartes Systems Group will announce its second quarter fiscal 2027 financial results after market close on September 10, 2026. The company's executive management will host a conference call and webcast to discuss the results, providing investors and stakeholders with insight into its performance in the logistics technology sector.
Larimar Therapeutics reported encouraging long-term safety and efficacy data for nomlabofusp in an open-label study for Friedreich's ataxia, submitted the first module of a rolling Biologics License Application with the FDA seeking accelerated approval, and plans to start a global Phase 3 confirmatory study in Q3 2026. The company has a strong cash…
On Aug. 4, Pfizer reported second-quarter adjusted earnings that surpassed analyst expectations, driven by robust demand for the blood thinner Eliquis. The company slightly raised the lower end of its full-year sales forecast and highlighted its strategy to rely more on newer medicines and the $10 billion Metsera acquisition to diversify revenue aw…
JPMorgan said hedge funds gave up almost 3% of their 2026 gains during July as technology-related positions were unwound amid a wider market reaction to a crude oil price spike linked to the Iran war. Despite the setback, hedge funds remain approximately 8% higher for the year across strategies. The bank highlighted concentrated losses from momentu…
AMD reports second-quarter 2026 results after the close with consensus at $1.61 in EPS and $11.29 billion in revenue. Pre-market trading shows the stock up to $502.30, but history and current market positioning suggest that even a beat may not be sufficient to lift the share price unless management delivers clear guidance on Helios ramp timing, gro…
Rhythm Pharmaceuticals announced promising preliminary Phase 2 data for RM-718, an investigational MC4R agonist, demonstrating an average 11.6% reduction in BMI at 16 weeks among patients with acquired hypothalamic obesity. These results are comparable to existing treatments, with minimal adverse effects such as mild injection site hyperpigmentatio…
Kimco Realty Corporation, a leading US REIT specializing in open-air, grocery-anchored shopping centers, announced solid second quarter 2026 results highlighted by record portfolio occupancy of 96.4%, 4.5% growth in funds from operations (FFO) per share, and a 12% dividend increase. The company also raised its full-year 2026 net income and FFO outl…
The Scotts Miracle-Gro Company announced its mid-range financial targets and capital allocation strategy for fiscal years 2027 to 2029 during its Investor Day 2026 at the NYSE. The company outlined its SMG 2.0 growth strategy focusing on portfolio innovation, omnichannel expansion, market penetration, and operational excellence through technology. …
Senmiao Technology Limited (Nasdaq: AIHS) has hired a strategic government relations advisory firm led by Justin Evans to aid in site development, permitting, incentives, and government stakeholder engagement for its AI data center (AIDC) projects in the United States. This partnership aims to support the company's expansion efforts, including its …
BioNTech SE reported its second quarter 2026 financial results showing decreased revenues primarily due to reduced demand for its COVID-19 vaccines, increased R&D and SG&A expenses driven by oncology pipeline advancements and acquisition integration, and a widened net loss. The company advanced its oncology pipeline with multiple pivotal trials ini…
Descartes Systems Group introduced its new AI-powered Free Trade Intelligence (FTI) solution designed to assist manufacturers, importers, and exporters in reducing trade costs by facilitating faster and more accurate qualification for preferential tariff treatment. The solution integrates with ERP systems and leverages AI to analyze complex trade d…
Alphabet's fundamentals and free cash flow combine with an apparent multi-hundred-billion AI backlog to create a compelling mid-term long trade. The stock trades at an attractive 18x earnings with healthy margins and a fortress-like balance sheet; this trade targets accelerated multiple expansion as AI infrastructure spending converts to recurring …
A 37-year-old Spokane resident has been arrested on suspicion of deliberately starting the Old Trails Fire, one of three fast-moving blazes that ignited north and west of Spokane over the weekend. The fires have scorched more than 10,000 acres, destroyed or damaged hundreds of structures and prompted evacuation orders for tens of thousands of resid…
Indian equity benchmarks closed lower on Tuesday, with the Nifty 50 losing 0.64% and the BSE Sensex 30 falling 0.27%. Declines were broad-based, led by Real Estate, Fast Moving Consumer Goods and Healthcare names, even as select industrial and financial stocks posted gains. Volatility edged higher and commodity prices, including crude oil and gold …
Chatham Lodging Trust, a REIT specializing in upscale hotels, announced robust second quarter 2026 financial results showing a 3% increase in RevPAR and a 22% surge in AFFO per diluted share to $0.48. Key markets including Silicon Valley and newly acquired hotels outperformed expectations, contributing to margin expansions and solid net income rise…
